BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With Novartis committing $750M to ProFound Therapeutics to dis
 cover new cardiovascular candidates\, and Illumina acquiring SomaLogic fo
 r $425 to expand its proteomic capabilities just this year alone\, the in
 creasing recognition of proteomics as a transformative force in drug disc
 overy is unquestionable.\n\nReturning to Boston for its second year\, the
  Proteomics-Based Drug Discovery Summit is the premier industry event ded
 icated to harnessing the full power of proteomics across drug discovery p
 ipelines. Designed for scientific innovators like you\, explore how next-
 generation proteomic platforms are accelerating understanding of patholog
 y\, unveiling novel drug targets\, and transforming hit-to-lead developme
 nt.\n\nWith a special focus on optimizing proteomics instruments to balan
 ce throughput and sensitivity\, automating sample processing\, unveiling 
 hidden disease mechanisms with PTM analysis\, and defining gold-standard 
 analysis methodologies\; this forum is ideal for proteomics leaders aimin
 g to expand the druggable proteome and achieve therapeutic options for di
 seases with unmet need.\n\nAs proteomics continues to evolve\, make headl
 ines\, and revolutionize therapeutic development\, unite with 70+ Directo
 rs\, Vice President and Experts in Proteomics\, Chemical Biology\, Mass S
 pectrometry and Bioinformatics to achieve protein level insights to advan
 ce your own discovery pipeline.\n\n&nbsp\;\n\nDate and Time: On Tuesday F
 ebruary 03\, 2026 at 8:00 am to Thursday February 05\, 2026 at 4:15 pm\n\
 nVenue details: Revere Hotel Boston Common\, 200 Stuart Street\, Boston\,
  Massachusetts\, 02116\, United States\n
DTEND:20260205T161500
DTSTAMP:20260512T232950Z
DTSTART:20260203T080000
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massach
 usetts\, 02116\,
SEQUENCE:0
SUMMARY:With Novartis committing $750M to ProFound Therapeutics to discove
 r new cardiovascular candidates\, and Illumina acquiring SomaLogic for $4
 25 to exp...
UID:d8cf7cba-1114-40b5-8773-9fd1b657de3d
END:VEVENT
END:VCALENDAR
